Literature DB >> 11891031

AH6809 antagonizes non-small cell lung cancer prostaglandin receptors.

Marchessini Casibang1, Terry W Moody.   

Abstract

The effects of prostaglandin (PG)E2 on lung cancer cells were investigated. 3H-PGE2 bound with high affinity to membranes derived from small cell lung cancer (SCLC) and non-SCLC (NSCLC) cell lines. Using NSCLC NCI-H1299 membranes, specific 3H-PGE2 binding to NCI-H1299 membranes was inhibited with moderate affinity by PGE2, PGE1, PGF2alpha and 6-isopropoxy-9-xanthone-2-carboxylic acid (AH6809) but not PGD2, LTB4 or 5-HETE. By RT-PCR, EP2 receptor PCR products were detected in extracts derived from lung cancer cells. PGE2 caused cAMP elevation in a concentration-dependent manner using NCI-H1299 cells and the increase in cAMP caused by PGE2 was antagonized by AH6809. PGE2 had no effect on cytosolic Ca2+ but PGE2 caused increased c-fos mRNA in NCI-H1299 cells. AH6809 inhibited the proliferation of NCI-H1299 cells using MTT and clonogenic assays. These results indicate that functional PG receptors are present on NSCLC cells which are antagonized by AH6809.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11891031     DOI: 10.1016/s0169-5002(01)00476-7

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  9 in total

1.  Piracy of prostaglandin E2/EP receptor-mediated signaling by Kaposi's sarcoma-associated herpes virus (HHV-8) for latency gene expression: strategy of a successful pathogen.

Authors:  Arun George Paul; Neelam Sharma-Walia; Nagaraj Kerur; Carl White; Bala Chandran
Journal:  Cancer Res       Date:  2010-04-13       Impact factor: 12.701

2.  Dithiolethione modified valproate and diclofenac increase E-cadherin expression and decrease proliferation of non-small cell lung cancer cells.

Authors:  Terry W Moody; Christopher Switzer; Wilmarie Santana-Flores; Lisa A Ridnour; Marc Berna; Michelle Thill; Robert T Jensen; Anna Sparatore; Piero Del Soldato; Grace C Yeh; David D Roberts; Giuseppe Giaccone; David A Wink
Journal:  Lung Cancer       Date:  2009-07-23       Impact factor: 5.705

3.  Inhibition of human glioma cell growth by a PHS-2 inhibitor, NS398, and a prostaglandin E receptor subtype EP1-selective antagonist, SC51089.

Authors:  Muneaki Matsuo; Nobuyuki Yoshida; Masahumi Zaitsu; Kiyohisa Ishii; Yuhei Hamasaki
Journal:  J Neurooncol       Date:  2004-02       Impact factor: 4.130

4.  Cyclooxygenase Inhibition Alters Proliferative, Migratory, and Invasive Properties of Human Glioblastoma Cells In Vitro.

Authors:  Matthew Thomas Ferreira; Juliano Andreoli Miyake; Renata Nascimento Gomes; Fábio Feitoza; Pollyana Bulgarelli Stevannato; Andrew Silva da Cunha; Fernanda de Oliveira Serachi; Alexandros Theodoros Panagopoulos; Alison Colquhoun
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

5.  Anti- and Protumorigenic Effects of PPARγ in Lung Cancer Progression: A Double-Edged Sword.

Authors:  Howard Li; Mary C M Weiser-Evans; Raphael Nemenoff
Journal:  PPAR Res       Date:  2012-08-12       Impact factor: 4.964

6.  Crosstalk between EP2 and PPARα Modulates Hypoxic Signaling and Myopia Development in Guinea Pigs.

Authors:  Nethrajeith Srinivasalu; Sen Zhang; Renchang Xu; Peter Sol Reinach; Yongchao Su; Yun Zhu; Jia Qu; Xiangtian Zhou
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-07-01       Impact factor: 4.799

7.  An oxidative stress-related prognostic signature for indicating the immune status of oral squamous cell carcinoma and guiding clinical treatment.

Authors:  Wei Lu; Changwei Yin; Tianqi Zhang; Yihua Wu; Shengyun Huang
Journal:  Front Genet       Date:  2022-09-23       Impact factor: 4.772

Review 8.  Cyclooxygenase-2-prostaglandin E2-eicosanoid receptor inflammatory axis: a key player in Kaposi's sarcoma-associated herpes virus associated malignancies.

Authors:  Arun George Paul; Bala Chandran; Neelam Sharma-Walia
Journal:  Transl Res       Date:  2013-04-06       Impact factor: 7.012

9.  Mechanism of Na-K-ATPase Inhibition by PGE2 in Intestinal Epithelial Cells.

Authors:  Niraj Nepal; Subha Arthur; Jennifer Haynes; Balasubramanian Palaniappan; Uma Sundaram
Journal:  Cells       Date:  2021-03-29       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.